Table 3.

Unadjusted and adjusted odds ratios for attendance at 1^st HCV treating specialist appointment (n=155).

Characteristic	Unadjusted OR (95% CI)	Adjusted OR (95% CI)
Age
Birth Cohorta member vs. Non-Birth Cohort	2.4(1.2–4.9)	1.7 (0.7–3.8)
Sex
Male vs Female	1.8 (0.9–3.7)	1.7 (0.7–3.8)
Race/Ethnicity
Non-Black vs. Black	2.5 (1.0–6.3)	2.4 (0.9–6.5)
HIV status
Positive vs. Negative	1.9 (0.3–10.5)	2.4 (0.4–15.7)
Drug use
Ever IDU	0.8 (0.4–1.7)	N/A
Current IDU (past 12 months)	0.8 (0.3–1.9)	1.3 (0.5–3.5)
Non-IDU (past 12 months)	0.6 (0.3–1.3)	N/A
Hazardous alcohol consumption*b
Yes vs. No	0.3 (0.1–0.8)	0.4 (0.1–0.9)
Health insurance*
No vs Yes	0.4 (0.1-0.2-0.9)	0.4 (0.1–0.9)
Linkage to care effort scorec
>9 vs. 0–9	0.3 (0.2–0.7)	NA

^aBirth Cohort: Individuals born between 1945 and 1965, as defined by the CDC.

^bHazardous alcohol consumption defined as reported use of ≥4 alcoholic drinks in 1 sitting or risky sex under the influence of alcohol in the preceding 30 days.

^cLinkage to care effort score: The linkage to care effort score is a summation of the weighted outreach efforts for each patient. A score for outreach effort was created by scaling encounters according to effort required. Phone calls, letters, and home visits were weighted as 1, 2, and 3, respectively.

^*Statistically significant at P<0.05 in the multivariable analysis

Ever-IDU, non-IDU and Linkage to care effort score were not included in the multivariable analysis

Abbreviations used in the table:

Ever IDU: History of injection drug use more than 12 months ago.

Current IDU: Current (within the past 12 months) injection drug use

Non-IDU: Non injection drug use within the past 12 months

HIV: Human Immunodeficiency Virus

MSM: Men who have Sex with Men

STD: Sexually Transmitted Disease

HCV: Hepatitis C Virus